Description |
interferon induced transmembrane protein 3 |
ELOVL fatty acid elongase 2 |
Image |
No pdb structure |
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Adverse response to drug ( 30420678)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Glycerophospholipid levels ( 26068415)
- Metabolic traits ( 21886157)
- Metabolite levels ( 22916037)
- Phospholipid levels (plasma) ( 22359512)
- Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid) ( 21829377)
- Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid) ( 24823311)
- Red blood cell fatty acid levels ( 25500335)
- Response to (pegylated) interferon in HBeAg-negative hepatitis B ( 30715261)
- Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1) ( 26503814)
- Serum metabolite ratios in chronic kidney disease ( 29545352)
|
Interacting Genes |
27 interacting genes:
ABHD16A
AQP6
CD53
ELOVL2
ERGIC3
FAM210B
FFAR2
FKBP7
GLP1R
GPR37
GPRC5D
KIR2DL3
LYPD5
MS4A3
NEDD4
OPRM1
PLP1
PTAFR
REEP4
RETREG3
SGPL1
SLC10A1
SLC10A2
SLC16A7
TMEM14B
TMEM86B
VKORC1
|
4 interacting genes:
FXYD6
IFITM3
MALL
TMEM218
|
Entrez ID |
10410 |
54898 |
HPRD ID |
05719 |
16857 |
Ensembl ID |
ENSG00000142089
|
ENSG00000197977
|
Uniprot IDs |
Q01628
|
A0A024QZV3
Q9NXB9
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|